Lennart Mucke, M.D., director of the Gladstone Institute of Neurological Disease, will present the Cheves Smythe Distinguished Lecture on “Developing Better Treatments for Alzheimer’s Disease: The Long and Short of It.”
The lecture will be at 4 p.m., Tuesday, Feb. 28, in MSB 3.001.
A leading expert on Alzheimer’s disease, Mucke is also a professor of neurology and the Joseph B. Martin Distinguished Professor of Neuroscience at the University of California San Francisco (UCSF) with which the Gladstone is affiliated. He has dedicated his career to researching memory loss, with an emphasis on Alzheimer’s disease and related neurodegenerative disorders.
He is the recipient of numerous awards, including the Potamkin Prize from the American Academy of Neurology; the MetLife Foundation Award for Medical Research; the Khalid Iqbal Lifetime Achievement Award and Zenith Award from the Alzheimer’s Association; and the American Pacesetter Award from the ARCS Foundation.
Mucke chairs the senate of the German Center for Neurodegenerative Diseases (DZNE), served on the National Advisory Council on Aging for the National Institutes of Health, and the Medical Advisory Council of the Alzheimer’s Association.
The Cheves Smythe Distinguished Lecture was established in 2006 to honor Cheves Smythe, M.D., the first dean of McGovern Medical School from 1970 – 1975. Smythe skillfully guided the School through its early years with his long-standing commitment to the fields of geriatrics and education and his exemplary standards of leadership. For more information, visit https://med.uth.edu/researchaffairs/cheves-smythe-distinguished-lecture/